Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jonas Leichsenring
Observed names:
J. Leichsenring,
Leichsenring Jonas,
Leichsenring, J.,
Leichsenring, Jonas
Institution:
BioNTech (Germany)
Observed institutions:
German Cancer Research Center,
Heidelberg University,
University Hospitals of the Ruhr-University of Bochum,
University Hospital Heidelberg,
Klinikum Coburg,
BioNTech (Germany),
St. Josef-Hospital,
Ruhr University Bochum
show all 8
ORCID:
0009-0008-1661-1881
Observed ORCID:
0009-0008-1661-1881
OpenAlex ID:
A5112357996
Implementing tumor mutational burden (TMB) analysis in routine diagnostics—a primer for molecular pathologists and clinicians
2018
·
Michael Allgäuer
, Jan Budczies
, et al.
·
Translational Lung Cancer Research
·
210
PDF
Size matters: Dissecting key parameters for panel‐based tumor mutational burden analysis
2018
·
Ivo Buchhalter
, Eugen Rempel
, et al.
·
International Journal of Cancer
·
155
Targeted Therapy in Advanced Melanoma With Rare BRAF Mutations
2019
·
Christian Menzer
, Alexander M. Menzies
, et al.
·
Journal of Clinical Oncology
·
134
PDF
Variant classification in precision oncology
2019
·
Jonas Leichsenring
, Peter Horak
, et al.
·
International Journal of Cancer
·
129
PDF
Measurement of tumor mutational burden (TMB) in routine molecular diagnostics: in silico and real‐life analysis of three larger gene panels
2018
·
Volker Endris
, Ivo Buchhalter
, et al.
·
International Journal of Cancer
·
106
PDF
Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics: Analysis of the first 3,000 Heidelberg cases
2019
·
Anna‐Lena Volckmar
, Jonas Leichsenring
, et al.
·
International Journal of Cancer
·
102
PDF
Pan‐cancer analysis of copy number changes in programmed death‐ligand 1 (PD‐L1, CD274) – associations with gene expression, mutational load, and survival
2016
·
Jan Budczies
, Michael Bockmayr
, et al.
·
Genes Chromosomes and Cancer
·
98
Spatial and Temporal Heterogeneity of Panel-Based Tumor Mutational Burden in Pulmonary Adenocarcinoma: Separating Biology From Technical Artifacts
2019
·
Daniel Kazdal
, Volker Endris
, et al.
·
Journal of Thoracic Oncology
·
94
PDF
Patients Resistant Against PSMA-Targeting α-Radiation Therapy Often Harbor Mutations in DNA Damage-Repair–Associated Genes
2019
·
Clemens Kratochwil
, Frederik L. Giesel
, et al.
·
Journal of Nuclear Medicine
·
91
Testing NTRK testing: Wet‐lab and in silico comparison of RNA‐based targeted sequencing assays
2019
·
Nicole Pfarr
, Martina Kirchner
, et al.
·
Genes Chromosomes and Cancer
·
74
The Value of Prostate-specific Antigen Density for Prostate Imaging-Reporting and Data System 3 Lesions on Multiparametric Magnetic Resonance Imaging: A Strategy to Avoid Unnecessary Prostate Biopsies
2019
·
Magdalena Görtz
, Jan Philipp Radtke
, et al.
·
European Urology Focus
·
61
The BRCA2 mutation status shapes the immune phenotype of prostate cancer
2019
·
Maximilian Jenzer
, Peter Keß
, et al.
·
Cancer Immunology Immunotherapy
·
52
PDF
RNA-Based Detection of Gene Fusions in Formalin-Fixed and Paraffin-Embedded Solid Cancer Samples
2019
·
Martina Kirchner
, Olaf Neumann
, et al.
·
Cancers
·
47
PDF
Targeted molecular profiling reveals genetic heterogeneity of poromas and porocarcinomas
2017
·
Martina Bosic
, Martina Kirchner
, et al.
·
Pathology
·
46
Community-driven development of a modified progression-free survival ratio for precision oncology
2019
·
Andreas Mock
, Christoph E Heilig
, et al.
·
ESMO Open
·
43
PDF
Validating Comprehensive Next-Generation Sequencing Results for Precision Oncology: The NCT/DKTK Molecularly Aided Stratification for Tumor Eradication Research Experience
2018
·
Amelie Lier
, Roland Penzel
, et al.
·
JCO Precision Oncology
·
40
Detection of TP53 Mutations in Tissue or Liquid Rebiopsies at Progression Identifies ALK+ Lung Cancer Patients with Poor Survival
2019
·
Petros Christopoulos
, Steffen Dietz
, et al.
·
Cancers
·
39
PDF
Assigning evidence to actionability: An introduction to variant interpretation in precision cancer medicine
2021
·
Peter Horak
, Jonas Leichsenring
, et al.
·
Genes Chromosomes and Cancer
·
33
PDF
Tubular, lactating, and ductal adenomas are devoid of MED12 Exon2 mutations, and ductal adenomas show recurrent mutations in GNAS and the PI3K–AKT pathway
2016
·
Anna‐Lena Volckmar
, Jonas Leichsenring
, et al.
·
Genes Chromosomes and Cancer
·
30
Comparative genetic profiling aids diagnosis and clinical decision making in challenging cases of CUP syndrome
2019
·
Tilmann Bochtler
, Volker Endris
, et al.
·
International Journal of Cancer
·
28
PDF
Mutational profiles of Brenner tumors show distinctive features uncoupling urothelial carcinomas and ovarian carcinoma with transitional cell histology
2017
·
Nicole Pfarr
, Silvia Darb‐Esfahani
, et al.
·
Genes Chromosomes and Cancer
·
27
Targeted next‐generation sequencing enables reliable detection of HER2 (ERBB2) status in breast cancer and provides ancillary information of clinical relevance
2016
·
Nicole Pfarr
, Roland Penzel
, et al.
·
Genes Chromosomes and Cancer
·
26
Integrating proteomics into precision oncology
2020
·
Leonie W. Wahjudi
, Stephan Bernhardt
, et al.
·
International Journal of Cancer
·
25
PDF
Genetic profiling of melanoma in routine diagnostics: assay performance and molecular characteristics in a consecutive series of 274 cases
2018
·
Jonas Leichsenring
, Fabian Stögbauer
, et al.
·
Pathology
·
25
Combined Immunohistochemistry after Mass Spectrometry Imaging for Superior Spatial Information
2018
·
Katharina Kriegsmann
, Rémi Longuespée
, et al.
·
PROTEOMICS - CLINICAL APPLICATIONS
·
25
PDF
Show more works
View as search
Works count:
71
Citation count:
1,979
H-index:
25
I10-index:
33
Year
Topic
Type
